1. Recent advances of bispecific antibodies in solid tumors
   Shengnan Yu et al, 2017, Journal of Hematology & Oncology CrossRef
2. Mabfilin and Fabfilin - New antibody-scaffold fusion formats for multispecific targeting concepts
   Mathias Kahl et al, 2018, Protein Expression and Purification CrossRef
3. Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection
   Eugene A Zhukovsky et al, 2016, Current Opinion in Immunology CrossRef
4. A single-domain antibody-linked Fab bispecific antibody Her2-S-Fab has potent cytotoxicity against Her2-expressing tumor cells
   Aifen Li et al, 2016, AMB Express CrossRef
5. Construction of IgG–Fab2 bispecific antibody via intein-mediated protein trans-splicing reaction
   Risa Yamada et al, 2023, Scientific Reports CrossRef
6. Monoclonal antibody-based therapeutics, targeting the epidermal growth factor receptor family: from herceptin to Pan HER
   Shima Moradi-Kalbolandi et al, 2018, Journal of Pharmacy and Pharmacology CrossRef
7. A HER2 bispecific antibody can be efficiently expressed in Escherichia�coli with potent cytotoxicity
   Limin Lin et al, 2018, Oncology Letters CrossRef
8. Visualizing Spatial and Stoichiometric Barriers to Bispecific T-Cell Engager Efficacy
   Ran You et al, 2022, Cancer Immunology Research CrossRef